Sonnet BioTherapeutics Granted EU Patent for Innovative FHAB Technology
January 29, 2025 - 11:22
Sonnet BioTherapeutics has successfully obtained a patent from the European Patent Office (EPO) for its groundbreaking fully human albumin binding (FHAB) technology. This significant achievement underscores the company’s commitment to advancing therapeutic solutions that leverage the unique properties of human albumin.
The FHAB technology is designed to enhance the delivery and efficacy of various therapeutic agents, potentially transforming treatment options for patients with a range of medical conditions. By utilizing human albumin, Sonnet aims to improve the pharmacokinetics and bioavailability of drugs, thereby optimizing therapeutic outcomes.
This patent not only strengthens Sonnet's intellectual property portfolio but also positions the company as a leader in the biotherapeutics space. With the growing demand for innovative treatment modalities, the successful patent acquisition is expected to facilitate further research and development initiatives. The company is poised to explore new partnerships and collaborations to maximize the potential of its FHAB technology in the healthcare market.
MORE NEWS
February 28, 2026 - 09:34
Trump orders federal agencies to stop using Anthropic AI in dispute over safetyA directive from the Trump administration has mandated all U.S. federal agencies to immediately cease using artificial intelligence technology developed by Anthropic. The order, which also includes...
February 27, 2026 - 19:09
How DNA technology identified baby found in Columbus County landfill in 1979In a stunning resolution to a case that haunted Columbus County for nearly half a century, advanced DNA technology has finally identified an infant found in a local landfill in 1979 and led to the...
February 27, 2026 - 13:12
Tennessee House hearing highlights impaired driving concerns, TBI technology modernizationA recent hearing before Tennessee House lawmakers placed a dual spotlight on the ongoing battle against impaired driving and the critical need to modernize the state`s forensic capabilities....
February 26, 2026 - 22:21
American Landmark names chief innovation and technology officerAmerican Landmark, a prominent owner-operator with a focus on Sun Belt multifamily communities, has announced a key strategic appointment. The company has named Adam Smolyar as its first Chief...